BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6194125)

  • 1. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
    Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
    Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Morita Y; Mochizuki H; Suzuki Y
    Infect Immun; 1982 Oct; 38(1):243-50. PubMed ID: 6183209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin and inosiplex: a review of their present status in viral diseases.
    Chang TW; Heel RC
    Drugs; 1981 Aug; 22(2):111-28. PubMed ID: 6167418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effects of inosiplex in viral infections. The activity of inosiplex and its constituents (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Aug; 55(8):541-50. PubMed ID: 6173451
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inosiplex-dependent interferon production in vivo and in vitro].
    Amitina NN; Tazulakhova EB; Ershov FI
    Vopr Virusol; 1984; 29(3):310-2. PubMed ID: 6205514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of inosiplex on viral growth and experimental viral infections (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):490-500. PubMed ID: 6173450
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulatory activity of isoprinosine on experimental viral infections in avian models.
    Moya P; Alonso ML; Baixeras E; Ronda E
    Int J Immunopharmacol; 1984; 6(4):339-43. PubMed ID: 6207123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of inosiplex on host defense against infections (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):479-89. PubMed ID: 6173449
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoprinosine: an overview.
    Simon LN; Glasky AJ
    Cancer Treat Rep; 1978 Nov; 62(11):1963-9. PubMed ID: 83189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effects of inosiplex in viral infections. Comparison with other immunostimulants (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Aug; 55(8):551-7. PubMed ID: 6173452
    [No Abstract]   [Full Text] [Related]  

  • 11. Inosiplex: an immunomodulation model for the treatment of viral disease.
    Ginsberg T; Glasky AJ
    Ann N Y Acad Sci; 1977 Mar; 284():128-38. PubMed ID: 81634
    [No Abstract]   [Full Text] [Related]  

  • 12. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.
    Sliva J; Pantzartzi CN; Votava M
    Adv Ther; 2019 Aug; 36(8):1878-1905. PubMed ID: 31168764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of inosiplex on T lymphocytes. I. Influence on T cells with receptors for IgG (T gamma).
    De Simone C; Meli D; Sbricoli M; Rebuzzi E; Koverech A
    J Immunopharmacol; 1982; 4(1-2):139-52. PubMed ID: 6185596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inosiplex on the humoral and cell-mediated immune responses to intradermal human diploid cell rabies vaccine.
    Sriwanthana B; Phanuphak P; Thaweepathomwat M; Warrell MJ; Warrell DA; Suntharasamai P; Baer GM
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):543-9. PubMed ID: 2437660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection.
    Waldman RH; Ganguly R
    Ann N Y Acad Sci; 1977 Mar; 284():153-60. PubMed ID: 81636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency.
    Galbraith GM; Thiers BH; Fudenberg HH
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):224-30. PubMed ID: 6207216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of oral inosiplex treatment of recurrent herpes simplex virus infections.
    Kalimo KO; Joronen IA; Havu VK
    Arch Dermatol; 1983 Jun; 119(6):463-7. PubMed ID: 6190441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
    Miyoshi T; Ogawa S; Nobuhara M; Namba M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):440-4. PubMed ID: 6200078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon-inducing and antiviral effects of inosiplex in combination with high-molecular interferon inducers].
    Tazulakhova EB; Amitina NN; Ershov FI
    Biull Eksp Biol Med; 1985 Oct; 100(10):457-9. PubMed ID: 2413924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of immunocytes in interferon production in mice in response to inosiplex induction].
    Tazulakhova EB; Amitina NN; Paugle RA; Ershov FI; Lidak MIu
    Vopr Virusol; 1988; 33(2):184-8. PubMed ID: 2457988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.